Skip to main content

and
  1. Article

    Open Access

    Benefits for children with suspected cancer from routine whole-genome sequencing

    Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every ...

    Angus Hodder, Sarah M. Leiter, Jonathan Kennedy, Dilys Addy in Nature Medicine (2024)

  2. No Access

    Article

    Identification of an Activating PDGFRA Deletion in a Novel Sinonasal Soft Tissue Neoplasm

    Spindle cell tumours in the sinonasal area are diagnostically challenging. We identified a neoplasm that defied histopathological classification using current criteria.

    James A. Watkins, Helen Hatcher, Shalini Malhotra, Furrat Amen in Head and Neck Pathology (2023)

  3. Article

    Open Access

    The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer

    Whole-genome sequencing (WGS) of cancers is becoming an accepted component of oncological care, and NHS England is currently rolling out WGS for all children with cancer. This approach was piloted during the 1...

    Jamie Trotman, Ruth Armstrong, Helen Firth, Claire Trayers in British Journal of Cancer (2022)